Antimicrobial activity of synthetic bornyl benzoates against Trypanosoma cruzi

References

• Chagas C. Nova tripanosomiase humana. Estudo sobre a morfolojia e cyclo evolutivo do Schyzotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida no homem. Mem Inst Oswaldo Cruz. 1909;1:159–218.
   Google Scholar
• WHO. Chagas disease. Special Programme for Research and Training in Tropical Diseases, TDR. Geneva: WHO; 2010. Fact Sheet No.: 340.
   Google Scholar
• Dias JC. Elimination of Chagas disease transmission: perspectives. Mem Inst Oswaldo Cruz. 2009;104:41–5.
   PubMed Web of Science ®Google Scholar
• Coura JR, Borges-Pereira J. Chagas disease: 100 years after its discovery: a systemic review. Acta Trop. 2010;115:5–13.
   PubMed Web of Science ®Google Scholar
• Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14–21.
   PubMed Web of Science ®Google Scholar
• Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1:92–100.
   PubMedGoogle Scholar
• Urbina JA. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 2010;115:55–68.
   PubMed Web of Science ®Google Scholar
• Filardi LS, Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg. 1987;81:755–9.
   PubMed Web of Science ®Google Scholar
• León-Pérez F, Gómez-Garcia L, Alejandre-Aguilar R, López R, Monteón VM. Mexican Trypanosoma cruzi isolates: in vitro susceptibility of epimastigotes to anti-Trypanosoma cruzi drugs and metacyclic forms to complement-mediated lysis. Vector Borne Zoonotic Dis. 2007;7:330–6.
   PubMed Web of Science ®Google Scholar
• Izumi E, Ueda-Nakamura T, Dias Filho BP, Veiga Júnior VF, Nakamura CV. Natural products and Chagas’ disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat Prod Rep. 2011;28:809–23.
   PubMed Web of Science ®Google Scholar
• Uzel A, Guvensen A, Cetin E. Chemical composition and antimicrobial activity of the essential oils of Anthemis xylopoda O. Schwarz from Turkey. J Ethnopharmacol. 2004;95:151–4.
   PubMed Web of Science ®Google Scholar
• Orav A., Arak E, Raal A. Phytochemical analysis of the essential oil of Achillea millefolium L. from various European countries. Nat Prod Res. 2006;20:1082–8.
   PubMed Web of Science ®Google Scholar
• Wenqiang G, Shufen L, Ruixiang Y, Yanfeng H. Comparison of composition and antifungal activity of Artemisia argyi Lévl. et Vant inflorescence essential oil extracted by hydrodistillation and supercritical carbon dioxide. Nat Prod Res. 2006;20:992–8.
   PubMed Web of Science ®Google Scholar
• Mühlbauer RC, Lozano A, Palacio S, Reinli A, Felix R. Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone. 2003;32:372–80.
   PubMed Web of Science ®Google Scholar
• Dolder S, Hofstetter W, Wetterwald A, Mühlbauer RC, Felix R. Effect of monoterpenes on the formation and activation of osteoclasts in vitro. J Bone Miner Res. 2006;21:647–55.
   PubMed Web of Science ®Google Scholar
• Klar U, Graf H, Schenk O, Röhr B, Schulz H. New synthetic inhibitors of microtubule depolymerization. Bioorg Med Chem Lett. 1998;8:1397–402.
   PubMed Web of Science ®Google Scholar
• Kiuchi F, Itano Y, Uchiyama N, Honda G, Tsubouchi A, Nakajima-Shimada J, et al.. Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides. J Nat Prod. 2002;65:509–12.
   PubMed Web of Science ®Google Scholar
• Uchiyama N, Matsunaga K, Kiuchi F, Honda G, Tsubouchi A, Nakajima-Shimada J, et al.. Trypanocidal terpenoids from Laurus nobilis L. Chem Pharm Bull. 2002;50:1514–6.
   PubMed Web of Science ®Google Scholar
• Araya JE, Neira I, da Silva S, Mortara RA, Manque P, Cordero E, et al.. Diterpenoids from Azorella compacta (Umbelliferae) active on Trypanosoma cruzi. Mem Inst Oswaldo Cruz. 2003;98:413–8.
   PubMed Web of Science ®Google Scholar
• Saeidnia S, Gohari AR, Uchiyama N, Ito M, Honda G, Kiuchi F. Two new monoterpene glycosides and trypanocidal terpenoids from Dracocephalum kotschyi. Chem Pharm Bull. 2004;52:1249–50.
   PubMed Web of Science ®Google Scholar
• Leite JP, Oliveira AB, Lombardi JA, Filho JD, Chiari E. Trypanocidal activity of triterpenes from Arrabidaea triplinervia and derivatives. Biol Pharm Bull. 2006;29:2307–9.
   PubMed Web of Science ®Google Scholar
• Sanchez AM, Jimenez-Ortiz V, Sartor T, Tonn CE, García EE, Nieto M, et al.. A novel icetexane diterpene, 5-epi-icetexone from Salvia gilliessi is active against Trypanosoma cruzi. Acta Trop. 2006;98:118–24.
   PubMed Web of Science ®Google Scholar
• Brossi A, Cordell GA, editors. The alkaloids. San Diego, CA: Academic Press; 1992.
   Google Scholar
• Taylor CR, Leader JP, Singleton W, Munster EW, Falkner FC, O’Neil JA. Profile of trimazosin: an effective and safe antihypertensive agent. Am Heart J. 1983;106:1269–81.
   PubMed Web of Science ®Google Scholar
• Roth B, Strelitz JZ, Rauckman BS. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 2. C-Alkylation of pyrimidines with Mannich bases and application to the synthesis of trimethoprim and analogues. J Med Chem. 1980;23:379–84.
   PubMed Web of Science ®Google Scholar
• Eich E, Pertz H, Kaloga M, Schulz J, Fesen MR, Mazumder A, et al.. (−)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J Med Chem. 1996;39:86–95.
   PubMed Web of Science ®Google Scholar
• Barnes RP. Mesitoic acid and mesitoyl chloride. Org. Synth. Coll. 1955;3:553.
   Google Scholar
• Meyers AI, Mihelich ED. The synthetic utility of 2-oxazolines. Angew Chem Int Ed Engl. 1976;15:270–81.
   Web of Science ®Google Scholar
• Reuman M, Meyers AI. The synthetic utility of oxazolines in aromatic-substitution. Tetrahedron. 1985;41:837–60.
   Web of Science ®Google Scholar
• Goldenberg S, Contreras VT, Salles JM, Bonaldo MC, Lima Franco MP, Linss J, et al.. Facts and hypothesis on Trypanosoma cruzi differentiation. Mem Inst Oswaldo Cruz. 1984;79(Suppl.):39–44.
   Google Scholar
• Camargo EP. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop São Paulo. 1964;6:93–100.
   PubMedGoogle Scholar
• Contreras VT, Salles JM, Thomas N, Morel CM, Goldenberg S. In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol. 1985;16:315–27.
   PubMed Web of Science ®Google Scholar
• Nielsen J. Combinatorial synthesis of natural products. Curr Opin Chem Biol. 2002;6:297–305.
   PubMed Web of Science ®Google Scholar
• Bursch W. Multiple cell death programs: Charon’s lifts to Hades. FEMS Yeast Res. 2004;5:101–10.
   PubMed Web of Science ®Google Scholar
• Menna-Barreto RF, Corrêa JR, Cascabulho CM, Fernandes MC, Pinto AV, Soares MJ, et al.. Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi. Parasitology. 2009;136:499–510.
   PubMed Web of Science ®Google Scholar